Keywords: double-digit, pharma, sales, growth, boosts, rhone-poulenc, french
Double-Digit Pharma Sales Growth Boosts Rhone-Poulenc
Article | 29 April 1998
French chemicals and pharmaceuticals company Rhone-Poulenc achieved netincome of 873 million French francs ($145.6 million) in the first quarter of 1998, a rise ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
